OLIG2 antibody
GTX132732
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetOLIG2
Overview
- SupplierGeneTex
- Product NameOLIG2 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. ICC/IF: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID10215
- Target nameOLIG2
- Target descriptionoligodendrocyte transcription factor 2
- Target synonymsBHLHB1, OLIGO2, PRKCBP2, RACK17, bHLHe19, oligodendrocyte transcription factor 2, basic domain, helix-loop-helix protein, class B, 1, class B basic helix-loop-helix protein 1, class E basic helix-loop-helix protein 19, human protein kinase C-binding protein RACK17, oligodendrocyte lineage transcription factor 2, oligodendrocyte-specific bHLH transcription factor 2, protein kinase C-binding protein 2
- HostRabbit
- IsotypeIgG
- Protein IDQ13516
- Protein NameOligodendrocyte transcription factor 2
- Scientific DescriptionThis gene encodes a basic helix-loop-helix transcription factor which is expressed in oligodendroglial tumors of the brain. The protein is an essential regulator of ventral neuroectodermal progenitor cell fate. The gene is involved in a chromosomal translocation t(14;21)(q11.2;q22) associated with T-cell acute lymphoblastic leukemia. Its chromosomal location is within a region of chromosome 21 which has been suggested to play a role in learning deficits associated with Down syndrome. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Kakae M, Nakajima H, Tobori S, et al. The astrocytic TRPA1 channel mediates an intrinsic protective response to vascular cognitive impairment via LIF production. Sci Adv. 2023,9(29):eadh0102. doi: 10.1126/sciadv.adh0102Read this paper
- Lee JK, Santos PT, Chen MW, et al. Combining Hypothermia and Oleuropein Subacutely Protects Subcortical White Matter in a Swine Model of Neonatal Hypoxic-Ischemic Encephalopathy. J Neuropathol Exp Neurol. 2021,80(2):182-198. doi: 10.1093/jnen/nlaa132Read this paper
- Barati S, Kashani IR, Tahmasebi F, et al. Effect of mesenchymal stem cells on glial cells population in cuprizone induced demyelination model. Neuropeptides. 2019,75:75-84. doi: 10.1016/j.npep.2019.04.001Read this paper
- Baker EW, Kinder HA, Hutcheson JM, et al. Controlled Cortical Impact Severity Results in Graded Cellular, Tissue, and Functional Responses in a Piglet Traumatic Brain Injury Model. J Neurotrauma. 2019,36(1):61-73. doi: 10.1089/neu.2017.5551Read this paper
- Baker EW, Platt SR, Lau VW, et al. Induced Pluripotent Stem Cell-Derived Neural Stem Cell Therapy Enhances Recovery in an Ischemic Stroke Pig Model. Sci Rep. 2017,7(1):10075. doi: 10.1038/s41598-017-10406-xRead this paper
![ELISA analysis of antigen using GTX60398 OLIG2 antibody [1G11]. Red : Control antigen 100ng Purple : Antigen 10ng Green : Antigen 50ng Blue : Antigen 100ng](https://www.genetex.com/upload/website/prouct_img/normal/GTX60398/GTX60398_20170912_ELISA_w_23061123_935.webp)




